501 (Mirtazapine 45 mg)
Pill imprint 501 has been identified as Mirtazapine 45 mg.
Mirtazapine is used in the treatment of insomnia; major depressive disorder; anxiety; depression; hot flashes (and more), and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 45 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- 501
- Strength:
- 45 mg
- Color:
- White
- Size:
- 15.80 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Tetracyclic antidepressants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Caraco Pharmaceutical Laboratories
- National Drug Code (NDC):
- 57664-0501
- Inactive Ingredients:
- lactose monohydrate
corn starch
pregelatinized starch
silicon dioxide colloidal
magnesium stearate
hydroxypropyl cellulose
hypromellose 2910
titanium dioxide
| NDC Code | Manufacturer / Repackager |
|---|---|
| 21695-0083 | Rebel Distributors Corp (repackager) |
Note: Inactive ingredients may vary.
More about mirtazapine
Consumer resources
- Other brands: Remeron, Remeron SolTab
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
